Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study

By sjmartinez • February 17, 2025

McLaren J, Chon Y, Gorski KS, Bernstein JA, Corren J, Hayama K, Jain V, Lima H, Sofen H, Ponnarambil S, Molfino NA, Maurer M. Tezepelumab for the Treatment of Chronic Spontaneous Urticaria: Results of the Phase 2b INCEPTION Study. J Allergy Clin Immunol. 2025 Feb 14:S0091-6749(25)00172-1. doi: 10.1016/j.jaci.2025.01.045. Epub ahead of print. PMID: 39956278.

Tags: Chronic spontaneous urticaria, Dermatology, INCEPTION, Publications, Tezepelumab, thymic stromal lymphopoietin, TSLP

Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides

Qin M, Evron E, Tran PT, Deng M, Nelson AM, Kim J, Agak GW. Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides.[...]

Frailty in lung transplant recipients is associated with anemia and telomere dysfunction but independent of epigenetic age

Kapse B, Mohanty RP, Wax M, Gao Y, Tran L, Wolters PJ, Pellegrini M, Singer JP, Greenland JR. Frailty in lung transplant recipients is associated[...]

Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection

Yan MJ, Phan H, Hsu S, Kang Y, Yu Y. Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection. Cureus. 2025 Apr[...]